Mannatech to Celebrate 15 Years of Ambrotose Products, Introduce
Social Entrepreneurship Platform at MannaFest 2011
Social Entrepreneurship Platform at MannaFest 2011
COPPELL, Texas, Mar 08, 2011 (BUSINESS WIRE) --
Mannatech, Incorporated(NASDAQ: MTEX), will announce new company initiatives related to its focus on health, wellness and skin care at its international conference, MannaFest SM 2011, March 10-12. The event will include a celebration of 15 years of Mannatech's flagship Ambrotose(R) products and a new platform for global social entrepreneurism.
Additionally, the leading developer and provider of nutritional supplements and skin care products based on Real Food Technology(R) solutions will launch the revolutionary GI-ProBalance(TM) product, which was specially formulated to enhance the benefits of Ambrotose products.
The synbiotic (probiotic and prebiotic) product is a great-tasting, yogurt-flavored powder packaged in convenient, portable slimsticks. It stimulates immune function, supports proper digestion and GI-tract function, while improving absorption of nutrients.*
"Mannatech has received more than 45 patents in 30 nations for technology related to Ambrotose products, which is the foundation for every great product Mannatech has developed," said Robert A. Sinnott, PhD, MNS, co-CEO and chief science officer of Mannatech. "Over the past 15 years, we have developed many proprietary technologies, but none provide more reason for our 400,000 Independent Associates around the world to succeed in selling and promoting a lifestyle of wellness than our Ambrotose products."
Continuing to expand on the philanthropic pillars the company was founded on, Mannatech will launch its new social entrepreneurship platform in efforts to help promote, aid and optimize nutrition where it is needed most across the world through Mannatech's Give for Realâ" program. The program is a unique 'donation-through-consumption' initiative designed to help combat malnutrition.
Mannatech's Real Food Technology(R) solutions-inspired PhytoBlend(TM) powder provides one of the best strategies for addressing this crisis because it is developed from food-sourced, naturally occurring ingredients chosen from those scientifically proven to best benefit the human body.
On Thursday evening, the keynote will be delivered by Dr. Benjamin Carson, the first doctor to successfully separate twins conjoined at the back of the head, the youngest director of pediatric neurosurgery in the history of Johns Hopkins Hospital, and recipient of the Presidential Medal of Freedom. Dr. Carson will present the event's keynote address on the benefits he personally experienced when combining glyconutrients with standard of care medical treatments.
"Dr. Carson is both a remarkably skilled surgeon and a great philanthropist," said Sinnott. "His dedication to health and nurturing the human mind and spirit has served as a guiding inspiration for Mannatech."
Individuals interested in Mannatech's products or exploring its business opportunity can learn more at Mannatech.com.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
About Mannatech
Mannatech, Incorporated, develops high-quality health, weight and fitness, and skin care products that are based on the solid foundation of nutritional science and development standards. Mannatech is dedicated to its platform of Social Entrepreneurism based on the foundation of promoting, aiding and optimizing nutrition where it is needed most around the world. Mannatech's proprietary products are available through independent sales Associates around the globe including the United States, Canada, South Africa, Australia, New Zealand, Austria, Denmark, Germany, Norway, Sweden, the Netherlands, the United Kingdom, Japan, Taiwan, Singapore, the Republic of Korea and Mexico. For more information, visit Mannatech.com.
Please note: This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as "intend" or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech's objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties and other factors. Some of these factors include, among others, Mannatech's inability to attract and retain Associates and Members, increases in competition, litigation, regulatory changes and its planned growth into new international markets. Although Mannatech believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.
SOURCE: Mannatech, Incorporated
for Mannatech, Incorporated
Allison Lowe Burum, 972-499-6631
Allison.Lowe@hck2.com